Tobin Schilke - Net Worth and Insider Trading
Tobin Schilke Net Worth
The estimated net worth of Tobin Schilke is at least $796,904 dollars as of 2024-11-13. Tobin Schilke is the CFO of Revance Therapeutics Inc and owns about 192,666 shares of Revance Therapeutics Inc (RVNC) stock worth over $795,711. Tobin Schilke is also the CFO of Achaogen Inc and owns about 47,748 shares of Achaogen Inc (AKAOQ) stock worth over $1,194. Details can be seen in Tobin Schilke's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tobin Schilke has not made any transactions after 2024-03-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Tobin Schilke
Tobin Schilke Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tobin Schilke owns 2 companies in total, including Revance Therapeutics Inc (RVNC) , and Achaogen Inc (AKAOQ) .
Click here to see the complete history of Tobin Schilke’s form 4 insider trades.
Insider Ownership Summary of Tobin Schilke
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RVNC | Revance Therapeutics Inc | 2024-03-18 | Chief Financial Officer |
| AKAOQ | Achaogen Inc | 2018-06-26 | Chief Financial Officer |
Tobin Schilke Latest Holdings Summary
Tobin Schilke currently owns a total of 2 stocks. Among these stocks, Tobin Schilke owns 192,666 shares of Revance Therapeutics Inc (RVNC) as of March 18, 2024, with a value of $795,711 and a weighting of 99.85%. Tobin Schilke also owns 47,748 shares of Achaogen Inc (AKAOQ) as of June 26, 2018, with a value of $1,194 and a weighting of 0.15%.
Latest Holdings of Tobin Schilke
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RVNC | Revance Therapeutics Inc | 2024-03-18 | 192,666 | 4.13 | 795,711 |
| AKAOQ | Achaogen Inc | 2018-06-26 | 47,748 | 0.03 | 1,194 |
Holding Weightings of Tobin Schilke
Tobin Schilke Form 4 Trading Tracker
According to the SEC Form 4 filings, Tobin Schilke has made a total of 10 transactions in Revance Therapeutics Inc (RVNC) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Revance Therapeutics Inc is the sale of 9,361 shares on March 18, 2024, which brought Tobin Schilke around $47,179.
According to the SEC Form 4 filings, Tobin Schilke has made a total of 0 transactions in Achaogen Inc (AKAOQ) over the past 5 years. The most-recent trade in Achaogen Inc is the sale of 298 shares on June 26, 2018, which brought Tobin Schilke around $2,858.
Insider Trading History of Tobin Schilke
- 1
Tobin Schilke Trading Performance
Tobin Schilke Ownership Network
Ownership Network List of Tobin Schilke
Ownership Network Relation of Tobin Schilke
Tobin Schilke Owned Company Details
What does Revance Therapeutics Inc do?
Who are the key executives at Revance Therapeutics Inc?
Tobin Schilke is the Chief Financial Officer of Revance Therapeutics Inc. Other key executives at Revance Therapeutics Inc include President Dustin S Sjuts , SVP & GC & Secretary Dwight Moxie , and director & CEO and President L Daniel Browne .
Revance Therapeutics Inc (RVNC) Insider Trades Summary
Over the past 18 months, Tobin Schilke made 4 insider transaction in Revance Therapeutics Inc (RVNC) with a net sale of 35,664. Other recent insider transactions involving Revance Therapeutics Inc (RVNC) include a net sale of 124,284 shares made by Mark J Foley , a net sale of 64,379 shares made by Dwight Moxie , and a net sale of 35,226 shares made by Dustin S Sjuts .
In summary, during the past 3 months, insiders sold 0 shares of Revance Therapeutics Inc (RVNC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 294,445 shares of Revance Therapeutics Inc (RVNC) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 264,445 shares.
Revance Therapeutics Inc (RVNC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Revance Therapeutics Inc Insider Transactions
Tobin Schilke Mailing Address
Above is the net worth, insider trading, and ownership report for Tobin Schilke. You might contact Tobin Schilke via mailing address: 7000 Shoreline Court, #371, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
